Cairo – Mubasher: Egypt’s Financial Regulatory Authority (FRA) approved to publish the disclosure form of Memphis Pharmaceutical and Chemical Industries to proceed in raising its authorised capital.
The disclosure form includes the board of directors’ decision, dated 27 July, to increase the company’s authorised capital by EGP 200 million to EGP 300 million, according to a bourse disclosure on Wednesday.
During fiscal year 2019/2020, the company achieved net profits of EGP 12.4 million, against net losses of EGP 25.38 million a year earlier.
